Qubit Pharmaceuticals participates in a mission to Japan with a view to partnering with Japanese pharmaceutical companies – Nikkei Biotech
Qubit Pharmaceuticals、日系製薬企業との提携を視野に来日ミッショ ンに参加 – 日経バイオテク
フランスのQubit Pharmaceuticalsとソルボンヌ大学が開発した量子エミュレーター Hyperion-1国家投資計画「フランス2030」により800万ユーロ（約13億円）の…
https://bio.nikkeibp.co.jp/atcl/release/24/08/21/21345/
Qubit Pharmaceuticals participates in a mission to Japan with a view to partnering with Japanese pharmaceutical companies – Nikkei Biotech
Hyperion-1, a quantum emulator developed by France’s Qubit Pharmaceuticals and Sorbonne University, received 8 million euros (approximately 1.3 billion yen) from the national investment plan “France 2030”.
*Translated using Google’s automatic translation function. If there are any mistranslations, please contact us.
Comments